Pimavanserin tartrate
Pimavanserin tartrate is a selective 5-HT2A receptor inverse agonist employed in research on Parkinson's disease psychosis. It potently inhibits the NFAT signaling pathway and is utilized in both in vitro receptor studies and in vivo models of neuropsychiatric disorders.
Product Specifications
CAS Number
706782-28-7
Product Name Alternative
ACP103, ACP-103, ACP-103 hemitartrate, ACP103 Tartrate, ACP 103, ACP 103 Tartrate, 5-HT Receptor, 5-HT2A, 5HT Receptor, 5HTReceptor, Pimavanserin hemitartrate
Field of Research
Neuroscience, Pharmacology & Drug Discovery
Purity
99.24% (May vary between batches)
Solubility
Ethanol:93 mg/mL (92.52 mM) ;10% DMSO+40% PEG300+5% Tween-80+45% Saline:2.5 mg/mL (2.49 mM) ; DMSO:28.05 mg/mL (27.9 mM) ; H2O:92 mg/mL (91.52 mM)
Smiles
O[C@H] ([C@@H] (O) C (O) =O) C (O) =O.CC (C) COc1ccc (CNC (=O) N (Cc2ccc (F) cc2) C2CCN (C) CC2) cc1.CC (C) COc1ccc (CNC (=O) N (Cc2ccc (F) cc2) C2CCN (C) CC2) cc1
Molecular Formula
C50H68F2N6O4·C4H6O6
Molecular Weight
1005.2
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog